KL
INSIDER · ORKA · Oruka Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER
Klein Lawrence Otto
Every open-market transaction filed under this name, Sep 1 to Oct 1.
Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$9.2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 200 | $84.78 | $17K | −5.7% |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 8,554 | $84.03 | $719K | −4.9% |
| Oct 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 16,246 | $83.40 | $1.4M | −4.2% |
| Sep 15 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 2,452 | $95.71 | $235K | −16.5% |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 4,800 | $92.44 | $444K | −13.5% |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 63,596 | $91.90 | $5.8M | −13.0% |
| Sep 1 | ORKA | Oruka Therapeutics, Inc. | Chief Executive Officer | Sell | 6,604 | $90.79 | $600K | −12.0% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.